Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 480, pseudogene (RN7SL480P)
- Target
- RN7SL480P
- Molecular classification
- Pseudogene, Non-coding RNA pseudogene, Long non-coding RNA pseudogene (sometimes grouped in this family)
01
Overview
RNA, 7SL, cytoplasmic 480, pseudogene (RN7SL480P) is a pseudogene related to the functional 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP) complex essential for co-translational protein targeting to the endoplasmic reticulum[1][3]. Pseudogenes like RN7SL480P are typically non-functional genomic sequences derived from reverse transcription and genomic integration of the parental 7SL RNA, lacking promoter activity or essential structural features to produce a functional RNA[5]. While 7SL RNA pseudogenes are widespread in the human genome and sometimes discussed in the context of genome evolution or gene regulation as noncoding RNAs, there is no evidence that RN7SL480P has any functional role, involvement in disease, or relevance as a therapeutic target[5][6]. There are no drugs, biomarkers, or safety concerns associated with this pseudogene.
- Other names
- RN7SL480PRNA, 7SL, cytoplasmic 480, pseudogene
02
Mechanism of action
None (no drugs or therapeutics target RN7SL480P; pseudogenes are not pharmacological targets)
03
Biological functions
Other (pseudogenes may very rarely act in RNA-mediated regulation, but no function is established for RN7SL480P specifically)Potential genetic element involved in retrotransposition or genomic sequence evolution
04
Disease associations
Other (no disease role is established for RN7SL480P; in general, most pseudogenes are not disease-related, but some may contribute to gene regulation or serve as genetic markers in very specific cases)
05
Safety considerations
None (no safety or therapeutic challenges are attributed to this pseudogene)
06
Interacting drugs
None
07
Biomarkers
None
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 480, pseudogene (RN7SL480P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 480, pseudogene (RN7SL480P).